Fate Therapeutics Inc (NASDAQ:FATE)
| 5.51 Delayed Data As of Jun 06 |  +0.35 / +6.78%Today’s Change | 4.02 Today|||52-Week Range 37.13 | -45.39% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 2.4M | 4.4M | 4.1M | 4.7M | |
| Depreciation And Amortization | 687.0K | 881.0K | 971.0K | 1.2M | ||
| Operating Expenses | Gross Income | -- | -- | -- | -- | -- |
| General Expenses | 29.5M | 35.5M | 45.3M | 70.6M | ||
| Research And Development | 19.2M | 25.6M | 33.4M | 54.8M | ||
| Total Operating Expenses | 30.2M | 36.4M | 46.2M | 71.8M | ||
| Non-Operating Expenses | Operating Income | -27.8M | -32.0M | -42.1M | -67.1M | |
| Extraordinary Charge | 0.00 | 0.00 | -118.0K | 0.00 | ||
| Interest Expense On Debt | 2.2M | 1.6M | 1.3M | 1.7M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -30.0M | -33.5M | -43.0M | -66.6M | |
| Net Income | -30.0M | -33.5M | -43.0M | -66.6M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 25.5M | 31.8M | 42.0M | 56.2M | |
| Shares To Calculate EPS Diluted | 25.5M | 31.8M | 42.0M | 56.2M | ||
| Earnings Per Share | EPS | -$1.18 | -$1.05 | -$1.02 | -$1.19 | |
| EPS Diluted | -$1.18 | -$1.05 | -$1.02 | -$1.19 | ||
